Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

GSK stock dips 0.6% after six-session gain streak. EU panel backs Blenrep for multiple myeloma, while FDA expands asthma ...

Some crystal methamphetamine seized in a huge drug bust in Guangdong province was made using the popular cold medicine Contac ... British drug maker GlaxoSmithKline (GSK), state media reported ...

UK-based pharmaceutical company GSK has reported positive outcomes from two Phase III trials of depemokimab for treating ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that GSK has ...

RESEARCH TRIANGLE PARK, N.C., June 2 GlaxoSmithKline (NYSE: GSK) today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling ...

* GSK - FULL-YEAR OUTLOOK EXPECT 2022 SALES GROWTH OF BETWEEN 6% TO 8% * GSK - SEES FULL-YEAR ADJUSTED OPERATING PROFIT GROWTH OF BETWEEN 13% TO 15% * GSK - SEES FY ADJUSTED EPS EXPECTED TO GROW ...